tektrotyd 20 mikrog
narodowe centrum badán jadrowych - hynic-[d-phe1,tyr3-oktreotid] trifluoracetat - preparasjonssett til radioaktive legemidler - 20 mikrog
ervebo
merck sharp & dohme b.v. - rekombinant vesicular stomatitis virus (belastning indiana) med en sletting av konvolutten glykoprotein, erstattet med zaire ebolavirus (belastning kikwit 1995) overflate glykoprotein - hemoragisk feber, ebola - vaksiner - ervebo is indicated for active immunization of individuals 1 year of age or older to protect against ebola virus disease (evd) caused by zaire ebola virus. bruk av ervebo skal være i samsvar med offisielle anbefalinger.
pamorelin 22.5 mg
institut produits synthèse (ipsen) ab - triptorelinembonat - pulver og væske til depotinjeksjonsvæske, suspensjon - 22.5 mg
tecartus
kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - lymfom, mantelcelle - antineoplastiske midler - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).
ectosan vet 1000 mg/ g
benchmark animal health norway as - imidakloprid - pulver til behandlingsoppløsning til fisk - 1000 mg/ g
icatibant glenmark 30 mg
glenmark arzneimittel gmbh - ikatibantacetat - injeksjonsvæske, oppløsning i ferdigfylt sprøyte - 30 mg
ganirelix gedeon richter
chemical works of gedeon richter plc. (gedeon richter plc.) - ganirelix acetate - reproductive techniques, assisted; ovulation induction; infertility, female - hypofysiske og hypotalamiske hormoner og analoger - prevention of premature luteinising hormone (lh) surges in women undergoing controlled ovarian hyperstimulation (coh) for assisted reproduction techniques (art).